Pemetrexed-Induced Typhlitis in Non-small Cell Lung Cancer
Open Access
- 1 October 2008
- journal article
- case report
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (10) , 1188-1190
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Improving patient management in metastatic non-small cell lung cancerLung Cancer, 2007
- Neutropenic enterocolitis: Current issues in diagnosis and managementCurrent Infectious Disease Reports, 2007
- Neutropenic enterocolitis in adults: systematic analysis of evidence qualityEuropean Journal of Haematology, 2005
- FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung CancerThe Oncologist, 2005
- Neutropenic Enterocolitis in Adults: Case Series and Review of the LiteratureDigestive Diseases and Sciences, 2005
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine.Cancer Chemotherapy and Pharmacology, 2001
- Typhlitis complicating autologous blood stem cell transplantation for breast cancerBone Marrow Transplantation, 2000
- Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumorsCancer, 1998
- Recurrent typhlitisDiseases of the Colon & Rectum, 1989